Weekly posts on small and mid-cap biotech stocks. 100% independent and reader supported with no company sponsored content or hedge fund compensation of any kind. See free performance posts for more information. Not financial advice, for research purposes.
| Platform |  | Pricing | Freemium | Publishes | Weekly |
|---|---|---|---|---|---|
| Issues | 104 | Founded | 6 years ago | Last Issue | 7 days ago |
| Active | |||||
Read this Newsletter
mattbiotech.substack.comLatest Issues
Q2 2026 Earnings Preview: What I'm Watching
TGTX, GERN, HROW, CGEM, ABVX, CELC, DCTH, TARS, EWTX, IDYA, XERS, EOLS, MNKD, VIR.
Word Count: 3,500 words, Reading Time: 17 minutes. Not financial advice, do your own due diligence, for entertainment purposes only.
Cullinan's Second, Third, And Fourth Pipeline Programs Could Be Standalone Companies
Despite a 80% run since the last time I wrote about CGEM the company remains extremely under-valued and under-appreciated. Still one of my largest positions.
Word Count: 5,275 words, Reading Time: 26 minutes. Not financial advice, do your...
Geron (Yes, Geron) Could Finally Create Shareholder Value In Late 2026 and 2027
Word Count: 6,665 words, Reading Time: 33 minutes.
Word Count: 7,010 words, Reading Time: 35 minutes. Not financial advice, do your own due diligence, for entertainment purposes only.
Destroying Six Bear Theses For Celcuity
I'm tired of hearing these lines of attack!
Word Count: 3,305 words, Reading Time: 15 minutes. Not financial advice, do your own due diligence, for entertainment purposes only.
Three Pieces Of Great News For TG Therapeutics And A Favorable Historical Comp
Greater than 500% total return in the next five years if I'm right.
Word Count: 3,389 words, Reading Time: 15 minutes. Not financial advice, do your own due diligence, for entertainment purposes only.
Audience Metrics
Subscribers, engagement, traffic and sponsorship for Matt Gamber’s Biotech Newsletter.
| Subscribers | Engagement | 72 | Monthly Web Visits | ||
|---|---|---|---|---|---|
| Accepts Sponsors | Estimated Cost per Ad | ||||
Chart Rankings
How this newsletter ranks in the official Substack charts.
| #132 |
Authors
The writers behind this newsletter.
Social
Frequently Asked Questions
How can I access the email archive for Matt Gamber’s Biotech Newsletter?
You can find recent issues that have been published by Matt Gamber’s Biotech Newsletter on Reletter by scrolling up to where it says Latest Issues. Tap on the link for any of the most recent emails or hit More Issues to see older ones.
How many subscribers does Matt Gamber’s Biotech Newsletter have?
To see how many people subscribe to Matt Gamber’s Biotech Newsletter, simply upgrade your Reletter account. We provide readership numbers and lots of other stats for this newsletter so you can decide if it's worth reaching out to.
How can I advertise in Matt Gamber’s Biotech Newsletter?
Newsletter advertising can be extremely effective when it's done right. Before you pitch Matt Gamber’s Biotech Newsletter as a potential sponsor or partner, make sure that you've done your research and checked its newsletter stats with Reletter.
Then, personalize one of our winning pitching templates and send it to the right person using the contact info provided.
How much does it cost to sponsor a publication like Matt Gamber’s Biotech Newsletter?
Newsletter ad rates (or CPM) vary depending on many factors, including industry, number of subscribers, open rate, ad placement and more.
To find out how much an ad will cost, contact Matt Gamber’s Biotech Newsletter using the contact information provided and ask for a copy of their media kit.
How can I find newsletters related to Matt Gamber’s Biotech Newsletter?
Scroll up to where it says Related Newsletters to see other publications like Matt Gamber’s Biotech Newsletter. You can also search our email newsletter directory to discover other newsletters that cover the topics you're interested in.
How do I contact Matt Gamber’s Biotech Newsletter?
Reletter provides this newsletter's website URL above, where you will often find their contact information. We also provide links to associated social media accounts and pitching templates so you can reach out fast.